Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 121
Filtrar
1.
Clin Exp Immunol ; 184(3): 293-307, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-26888163

RESUMO

Derailment of immune responses can lead to autoimmune type 1 diabetes, and this can be accelerated or even induced by local stress caused by inflammation or infection. Dendritic cells (DCs) shape both innate and adaptive immune responses. Here, we report on the responses of naturally occurring human myeloid BDCA1(+) DCs towards differentially stressed pancreatic ß cells. Our data show that BDCA1(+) DCs in human pancreas-draining lymph node (pdLN) suspensions and blood-derived BDCA1(+) DCs both effectively engulf ß cells, thus mimicking physiological conditions. Upon uptake of enterovirus-infected, but not mock-infected cells, BDCA1(+) DCs induced interferon (IFN)-α/ß responses, co-stimulatory molecules and proinflammatory cytokines and chemokines. Notably, induction of stress in ß cells by ultraviolet irradiation, culture in serum-free medium or cytokine-induced stress did not provoke strong DC activation, despite efficient phagocytosis. DC activation correlated with the amount of virus used to infect ß cells and required RNA within virally infected cells. DCs encountering enterovirus-infected ß cells, but not those incubated with mock-infected or stressed ß cells, suppressed T helper type 2 (Th2) cytokines and variably induced IFN-γ in allogeneic mixed lymphocyte reaction (MLR). Thus, stressed ß cells have little effect on human BDCA1(+) DC activation and function, while enterovirus-infected ß cells impact these cells significantly, which could help to explain their role in development of autoimmune diabetes in individuals at risk.


Assuntos
Antígenos CD1/imunologia , Comunicação Celular/imunologia , Células Dendríticas/imunologia , Enterovirus Humano B/imunologia , Glicoproteínas/imunologia , Células Secretoras de Insulina/imunologia , Animais , Antígenos CD1/genética , Técnicas de Cocultura , Meios de Cultura Livres de Soro/farmacologia , Células Dendríticas/citologia , Células Dendríticas/efeitos dos fármacos , Enterovirus Humano B/patogenicidade , Expressão Gênica , Glicoproteínas/genética , Interações Hospedeiro-Patógeno , Humanos , Células Secretoras de Insulina/efeitos dos fármacos , Células Secretoras de Insulina/patologia , Células Secretoras de Insulina/virologia , Interferon gama/farmacologia , Interleucina-1beta/farmacologia , Camundongos , Fagocitose/efeitos dos fármacos , Poli I-C/farmacologia , Cultura Primária de Células , Transdução de Sinais , Estresse Fisiológico , Fator de Necrose Tumoral alfa/farmacologia , Raios Ultravioleta
2.
J Med Virol ; 85(7): 1267-73, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23595636

RESUMO

In vitro studies with primary human pancreatic islets suggest that several enterovirus serotypes are able to infect and replicate in beta cells. Some enterovirus strains are highly cytolytic in vitro whereas others show virus replication with no apparent islet destruction. The capability to induce islet destruction is determined only partially by the virus serotype, since strain specific differences have been detected within some serotypes including echovirus 9 (E-9). In this study, the viral genetic factors determining the outcome of islet infection (i.e., destructive vs. benign) were investigated by constructing parallel infectious clones of lytic E-9-DM strain that was isolated from a small child at the clinical onset of type 1 diabetes. The capabilities of these clone-derived viruses to induce islet destruction were monitored and the lytic potential of clones was modified by site-directed mutagenesis. The lytic capabilities of these clone-derived viruses in human pancreatic islets were modified by a single amino acid substitution (T81A) in the capsid protein VP1. The data presented outline the importance of amino acid point mutations in the pathogenetic process leading to islet necrosis. However, although the amino acid substitution (T81A) modifies the lytic capabilities of E-9-DM strain-derived microvariant strains, it is likely that additional viral genetic determinants of pancreatic islet pathogenicity exist in other E-9 strains.


Assuntos
Substituição de Aminoácidos , Proteínas do Capsídeo/genética , Echovirus 9/fisiologia , Células Secretoras de Insulina/virologia , Liberação de Vírus , Replicação Viral , Células Cultivadas , Echovirus 9/genética , Echovirus 9/isolamento & purificação , Infecções por Echovirus/virologia , Humanos , Dados de Sequência Molecular , Análise de Sequência de DNA , Doadores de Tecidos
3.
Epidemiol Infect ; 141(12): 2658-62, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23507533

RESUMO

We report the outcome of an 11-year programme monitoring sewage water and acute flaccid paralysis (AFP) cases as part of the World Health Organization (WHO) strategy for polio eradication in the Slovak Republic (SR). Polioviruses (PV) and non-polio enteroviruses (NPEV), prior to and after the change in polio vaccination strategy, were detected. Sewage treatment plant samples from 48 localities spread over the Western, Central and Eastern regions and clinical material from AFP cases were examined. The WHO standard procedures were followed with regard to virus isolation and identification. There were 538 commonly detected human enteroviruses (HEVs) including 213 (40%) coxsackie B viruses (CBV), 200 (37%) echoviruses and 113 (21%) Sabin-like PVs (PV1, 2, 3) including vaccine-derived poliovirus (VDPV) isolates. The percentage of PV isolates fell from 66% to 30% during 2001-2005 and thereafter fell to zero. CBV5, CBV2 and echovirus 3 were the NPEVs endemic during the study period.


Assuntos
Infecções por Enterovirus/epidemiologia , Infecções por Enterovirus/virologia , Enterovirus/classificação , Enterovirus/isolamento & purificação , Esgotos/virologia , Adolescente , Criança , Pré-Escolar , Monitoramento Epidemiológico , Humanos , Eslováquia/epidemiologia
4.
Diabetologia ; 55(12): 3273-83, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22983635

RESUMO

AIMS/HYPOTHESIS: Virally induced inflammatory responses, beta cell destruction and release of beta cell autoantigens may lead to autoimmune reactions culminating in type 1 diabetes. Therefore, viral capability to induce beta cell death and the nature of virus-induced immune responses are among key determinants of diabetogenic viruses. We hypothesised that enterovirus infection induces a specific gene expression pattern that results in islet destruction and that such a host response pattern is not shared among all enterovirus infections but varies between virus strains. METHODS: The changes in global gene expression and secreted cytokine profiles induced by lytic or benign enterovirus infections were studied in primary human pancreatic islet using DNA microarrays and viral strains either isolated at the clinical onset of type 1 diabetes or capable of causing a diabetes-like condition in mice. RESULTS: The expression of pro-inflammatory cytokine genes (IL-1-α, IL-1-ß and TNF-α) that also mediate cytokine-induced beta cell dysfunction correlated with the lytic potential of a virus. Temporally increasing gene expression levels of double-stranded RNA recognition receptors, antiviral molecules, cytokines and chemokines were detected for all studied virus strains. Lytic coxsackievirus B5 (CBV-5)-DS infection also downregulated genes involved in glycolysis and insulin secretion. CONCLUSIONS/INTERPRETATION: The results suggest a distinct, virus-strain-specific, gene expression pattern leading to pancreatic islet destruction and pro-inflammatory effects after enterovirus infection. However, neither viral replication nor cytotoxic cytokine production alone are sufficient to induce necrotic cell death. More likely the combined effect of these and possibly cellular energy depletion lie behind the enterovirus-induced necrosis of islets.


Assuntos
Efeito Citopatogênico Viral/imunologia , Diabetes Mellitus Tipo 1/patologia , Enterovirus Humano B/imunologia , Infecções por Enterovirus/patologia , Animais , Células Cultivadas , Diabetes Mellitus Tipo 1/imunologia , Diabetes Mellitus Tipo 1/virologia , Enterovirus Humano B/patogenicidade , Infecções por Enterovirus/imunologia , Infecções por Enterovirus/virologia , Feminino , Regulação da Expressão Gênica , Humanos , Imunidade Inata , Imuno-Histoquímica , Inflamação , Interleucina-1alfa/imunologia , Interleucina-1beta/imunologia , Masculino , Camundongos , Pessoa de Meia-Idade , Necrose , Fator de Necrose Tumoral alfa/imunologia
5.
Bijblijven (Amst) ; 26(7): 7-13, 2010.
Artigo em Holandês | MEDLINE | ID: mdl-32287610
6.
Ned Tijdschr Geneeskd ; 152(42): 2302-4, 2008 Oct 18.
Artigo em Holandês | MEDLINE | ID: mdl-19009882

RESUMO

Currently, general practitioners and occupational health physicians in The Netherlands face the question whether their patients should be vaccinated against influenza. This follows the addition of two new groups to the list of persons to be vaccinated: those over sixty and people working in health care and health institutions with direct patient contact. These developments stir the hidden resistance to influenza vaccination. It should be clear to everyone that there is no doubt that the vaccination is efficacious and safe. However, the influenza activity in The Netherlands has been low over the last years, which limits the disease burden to be prevented byvaccination. Under these circumstances, the proportion of flu-like symptoms caused by other agents such as respiratory syncytial virus is increased, which may lead to the false impression that the influenza vaccine is not effective. A new pandemic may come at any time, and only then will the efforts to prevent influenza pay off.


Assuntos
Pessoal de Saúde , Vacinas contra Influenza/administração & dosagem , Influenza Humana/prevenção & controle , Aceitação pelo Paciente de Cuidados de Saúde , Vacinação/estatística & dados numéricos , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Fatores de Transcrição Hélice-Alça-Hélice Básicos , Proteínas de Drosophila , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Médicos de Família , Proteínas Repressoras , Fatores de Risco
7.
J Clin Virol ; 42(4): 321-5, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18359271

RESUMO

BACKGROUND: In The Netherlands the incidence of neonatal herpes was 2.0-2.9 per 100,000 live births during the period 1981-1998. The low incidence warranted a rather conservative prevention policy. OBJECTIVES: To monitor for potential changes in the incidence of neonatal herpes in The Netherlands between 1999 and 2005, which may affect the prevention policy. STUDY DESIGN: Questionnaires were sent to all virological laboratories, the gynaecological and paediatric departments of every university hospital and half the number of the general hospitals in The Netherlands. The questionnaires pertained to the incidence of proven cases of neonatal herpes, the numbers of caesarean sections performed for the prevention of neonatal herpes and the numbers of pregnant women with genital herpes. RESULTS: In the period 1999-2005 33 cases of neonatal herpes were reported, yielding an incidence of 3.2 cases per 100,000 live births per year. The estimated annual numbers of pregnant women with genital herpes ranged from 200 to 240. Approximately 9 caesarean sections were performed annually to prevent neonatal herpes. CONCLUSIONS: In The Netherlands neonatal herpes is still a rare condition. From the findings of this study it is concluded that it is not necessary to revise the Dutch guidelines for the prevention of neonatal herpes simplex infection.


Assuntos
Herpes Simples/epidemiologia , Cesárea , Feminino , Humanos , Incidência , Recém-Nascido , Masculino , Países Baixos/epidemiologia , Gravidez , Complicações Infecciosas na Gravidez/epidemiologia , Gestantes , Inquéritos e Questionários
9.
Ned Tijdschr Geneeskd ; 149(13): 680-4, 2005 Mar 26.
Artigo em Holandês | MEDLINE | ID: mdl-15819131

RESUMO

The report 'Emerging zoonoses' of the Health Council of the Netherlands was written on request from the Minister of Health, Welfare and Sport. It gives an expert view on how to anticipate zoonoses that could emerge in the near future by addressing questions regarding risk assessment, prevention, early detection, control and communication. Further emphasis in the report is given to developments within the European Union (EU). The report had to serve as the basis for a European policy conference on 16 and 17 September 2004 during the Dutch presidency of the EU. Some important developments announced by the Minister are: establishment of a National Centre for Infectious Diseases to advise the Minister and coordinate crisis control during outbreaks, measures to strengthen the regional structure of public health in the Netherlands, and a budget for the strengthening of public health research.


Assuntos
Doenças Transmissíveis Emergentes/prevenção & controle , Doenças Transmissíveis Emergentes/transmissão , Zoonoses , Humanos , Países Baixos , Saúde Pública , Medição de Risco , Gestão de Riscos
10.
Clin Infect Dis ; 40(3): 483-5, 2005 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-15668876

RESUMO

During 2 consecutive influenza seasons we investigated the presence of influenza virus, human herpesvirus (HHV) type 6, and HHV-7 in cerebrospinal fluid samples from 9 white children suffering from influenza-associated encephalopathy. We conclude that it is unlikely that neuroinvasion by influenza virus or reactivation of either HHV-6 or HHV-7 is involved.


Assuntos
Encefalopatias/virologia , Herpesvirus Humano 6/fisiologia , Herpesvirus Humano 7/fisiologia , Influenza Humana/complicações , Orthomyxoviridae/fisiologia , Ativação Viral , Encefalopatias/etiologia , Pré-Escolar , Humanos , Lactente , Infecções por Roseolovirus/complicações
11.
Ned Tijdschr Geneeskd ; 148(5): 238-9, 2004 Jan 31.
Artigo em Holandês | MEDLINE | ID: mdl-14983582

RESUMO

The revised Netherlands guideline 'Sexually transmitted diseases and neonatal herpes' recommends shortening of the follow-up period from 6 to 3 months for HIV-testing after a risky contact and a period of 6 months in case of post-exposure prophylaxis. The newly adopted follow-up period has a precedent in Sweden, where, based on the same scientific arguments, the follow-up period has been reduced to 3 months. There is little scientific information on which to base the optimal duration of the follow-up period. Therefore, two different periods are used in the Netherlands: 3 months for medical practice in the field of sexually transmitted diseases and 6 months for occupational exposure of health care workers and for blood products.


Assuntos
Fármacos Anti-HIV/administração & dosagem , Anticorpos Antivirais/sangue , Infecções por HIV/diagnóstico , Doenças Profissionais/prevenção & controle , Infecções Sexualmente Transmissíveis/tratamento farmacológico , Infecções por HIV/tratamento farmacológico , Infecções por HIV/prevenção & controle , Humanos , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Países Baixos , Guias de Prática Clínica como Assunto/normas , Fatores de Risco , Infecções Sexualmente Transmissíveis/prevenção & controle , Fatores de Tempo
12.
Ned Tijdschr Geneeskd ; 147(23): 1100-2, 2003 Jun 07.
Artigo em Holandês | MEDLINE | ID: mdl-12822517

RESUMO

The outbreak of avian influenza A due to an H7N7 virus in Dutch poultry farms turned out to have public-health effects for those who were involved in the management of the epidemic and who were thus extensively exposed to contaminated excreta and dust. An outbreak-management team (OMT) of experts in virology, infectious diseases and public health advised the Dutch government with respect to the potential health effects on humans. Strict hygiene measures were advised. Moreover, vaccination against human influenza was advised to prevent emergence of a new pandemic virus in humans. Since the human influenza virus H3N2 circulated at the same time, a double infection and emergence of a new human virus was the main fear on which prevention was focused. Conjunctivitis was observed in about 10% of the people involved. The conjunctivitis was sometimes accompanied by mild flu-like symptoms and incidental transmission between humans occurred as well. Because of the unexpected high incidence of symptomatic infections, proven to be caused by the H7N7 strain, oseltamivir was advised as an additional control measure, both for the treatment of symptoms and prophylactically for those with prolonged occupational exposure. After the unfortunate death of a veterinarian due to pneumonia caused by the avian virus, the preventive policy was further extended to people with short and incidental exposure to infected flocks. It is concluded that the policy was adequate, in spite of the unforeseen victim.


Assuntos
Acetamidas/administração & dosagem , Antivirais/administração & dosagem , Vírus da Influenza A/patogenicidade , Influenza Aviária/transmissão , Zoonoses , Acetamidas/uso terapêutico , Animais , Antivirais/uso terapêutico , Surtos de Doenças/veterinária , Humanos , Influenza Aviária/tratamento farmacológico , Influenza Aviária/prevenção & controle , Países Baixos/epidemiologia , Doenças Profissionais/prevenção & controle , Oseltamivir , Aves Domésticas , Saúde Pública , Estudos Retrospectivos , Especificidade da Espécie , Zoonoses/virologia
13.
Ned Tijdschr Geneeskd ; 147(15): 695-9, 2003 Apr 12.
Artigo em Holandês | MEDLINE | ID: mdl-12722532

RESUMO

The Dutch Institute for Health Care Improvement revised guideline, 'Sexually transmitted diseases and neonatal herpes' summarises the current scientific position on the diagnosis and treatment of a great number of sexually transmitted diseases (STD) and neonatal herpes. Symptomatic treatment of suspected Chlamydia trachomatis infection and gonorrhoea without previous diagnosis is not recommended. Treatment can be started immediately, once samples have been taken. Risk groups eligible for screening or proactive testing on C. trachomatis infection include: partners of C. trachomatis-positive persons, visitors of STD clinics, women who will undergo an abortion, mothers of newborns with conjunctivitis or pneumonitis, young persons of Surinam or Antillean descent, young women with new relationships and individuals whose history indicates risky sexual behaviour. A period of 3 months can be adopted between a risky contact and the HIV test (this used to be 6 months), unless post-exposure prophylaxis was used. For the treatment of early syphilis no distinction is drawn between HIV-infected and non-HIV-infected persons. It is no longer recommended that women in labour with a history of genital herpes are tested for the herpes simplex virus. Virological testing of the neonate is only advised if the mother shows signs of genital herpes during delivery.


Assuntos
Infecções Sexualmente Transmissíveis/tratamento farmacológico , Infecções por Chlamydia/tratamento farmacológico , Infecções por Citomegalovirus/tratamento farmacológico , Feminino , Gonorreia/tratamento farmacológico , Infecções por HIV/tratamento farmacológico , Hepatite B/tratamento farmacológico , Herpes Genital/tratamento farmacológico , Herpes Genital/prevenção & controle , Humanos , Recém-Nascido , Países Baixos , Papillomaviridae , Infecções por Papillomavirus/tratamento farmacológico , Gravidez , Fatores de Risco , Comportamento Sexual , Sífilis/tratamento farmacológico
14.
Neth J Med ; 61(11): 376-82, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14768722

RESUMO

INTRODUCTION: Epstein-Barr virus (EBV) establishes lifelong latent infection. In some patients the host-virus balance is disturbed, resulting in a chronic active EBV infection. The following case illustrates the difficulty in diagnosing and treating chronic EBV infection. CASE: A 30-year-old woman was referred because of recurrent swellings of lymphatic tissue of both eyelids, orbit and lymph nodes and general malaise since the age of 19. In the past, repeated biopsies showed MALT lymphoma and nonspecific lymphoid infiltrations. Now, a biopsy of an axillary lymph node showed paracortical hyperplasia with a polymorphous polyclonal lymphoid proliferation, and large numbers of EBV-encoded small RNA (EBER) positive cells, consistent with EBV infection. Laboratory investigation showed a high EBV viral load. No evidence of immunodeficiency was found. Chronic active EBV infection (CAEBV) was diagnosed. Treatment with high-dose acyclovir did not significantly reduce the viral load. Rituximab was given in an attempt to reduce the amount of EBV-infected B lymphocytes. However, soon after the second dose the patient died of a sub-arachnoidal haemorrhage. CONCLUSION: This case report illustrates CAEBV as a rare manifestation of EBV-induced disease, which will be detected more frequently with the use of EBV-EBER hybridisation of lymph nodes and polymerase chain reaction (PCR) for EBV DNA. The prognosis is poor with no established therapeutic strategies.


Assuntos
Infecções por Vírus Epstein-Barr/diagnóstico , Complicações Infecciosas na Gravidez/diagnóstico , Adulto , Doença Crônica , Diagnóstico Diferencial , Infecções por Vírus Epstein-Barr/tratamento farmacológico , Feminino , Humanos , Linfoma de Zona Marginal Tipo Células B/diagnóstico , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológico
15.
Diabetologia ; 45(5): 693-702, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12107750

RESUMO

AIMS/HYPOTHESIS: Direct infection of beta cells could explain the diabetogenic effect of enteroviruses. Primary adult human beta cells are susceptible to coxsackievirus infections, which could result in impaired beta-cell function or cell death (coxsackieviruses B3, B4, B5) or both, or no apparent immediate adverse effects (coxsackievirus A9). We extended these studies to additional enterovirus serotypes including several echoviruses, some of which have been associated clinically with the development of Type I (insulin-dependent) diabetes mellitus. METHODS: The patterns and consequences of enterovirus infections were investigated in cultured adult human isolated islets. Cell type-specific infection and viability were assessed by immunocytochemical methods. Beta-cell function was studied by perifusion. RESULTS: Poliovirus type 1/Mahoney, coxsackievirus A13, human parechovirus 1 and several echoviruses (serotypes 6, 7, 11) were capable of causing significant functional impairment ( p<0.05) and beta-cell death. In contrast, echovirus serotypes 9 and 30 were not destructive. However, when several different field isolates of echovirus 30 were investigated, some of them were found to be clearly more destructive than the corresponding prototype strain. This was also true for echovirus 9. A strain isolated from a 6-week-old baby suffering from acute Type I diabetes was functionally more destructive than either of the echovirus 9 prototype strains. CONCLUSION/INTERPRETATION: These observations indicate that the capacity of an enterovirus to kill human beta cells or impair their function is not entirely defined by the serotype, but in addition by as yet unidentified characteristics of the virus strain involved. Moreover, any serotype could potentially be diabetogenic.


Assuntos
Enterovirus Humano C/fisiologia , Enterovirus Humano C/patogenicidade , Ilhotas Pancreáticas/patologia , Ilhotas Pancreáticas/virologia , Adulto , Células Cultivadas , Enterovirus Humano C/classificação , Infecções por Enterovirus/patologia , Humanos , Sorotipagem , Replicação Viral
16.
Rev Med Virol ; 12(2): 93-106, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-11921305

RESUMO

Although fever is regarded as the main trigger in the pathogenesis of febrile seizures (FS), it is not supposed to be the unique causative factor. In FS, there is a strong familial predisposition. This does not exclude infections as a causative factor because subtle genetic polymorphisms have been demonstrated to affect the course of infections. We review the literature on: (1) the role of fever, especially the height of temperature, its cause, and metabolic effects induced by temperature; (2) the role of heredity; (3) the role of cytokines which play a role in the induction of fever; and (4) the role of type of infection, with emphasis on newly identified agents and improved diagnostic techniques. With modern molecular techniques such as PCR, viruses have been detected in the CSF far more often than previously thought, even in the absence of pleocytosis of the CSF. This makes it difficult to distinguish FS from acute encephalitis. FS may be caused by neuroinvasion or intracerebral activation of viruses. Further studies should focus on these options because therapeutic intervention is possible and may prevent late sequelae such as recurrent FS and subsequent epilepsy.


Assuntos
Febre , Convulsões Febris/etiologia , Convulsões Febris/fisiopatologia , Viroses/complicações , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Reação em Cadeia da Polimerase , Convulsões Febris/genética , Vírus/genética , Vírus/isolamento & purificação
17.
J Med Virol ; 66(2): 241-5, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11782934

RESUMO

The epidemiological, virological, and clinical data of 119 infants less than 30 days of age with enteroviral infection collected from January 1993 to November 1995 by the diagnostic virology laboratories were analyzed retrospectively. Ninety-eight isolates (83%) were obtained in the period of May 1 to December 1 with a peak in the summer months. Sixty-five percent (n = 78) of neonates became ill within the first 2 weeks of life. Echoviruses and Coxsackie virus type B were isolated most frequently, in 77 (65%) and 29 (24%) infants, respectively. Diagnosis was made by viral isolation from stool, nasopharyngeal swab, cerebrospinal fluid, and blood. One hundred four (87%) infants developed fever and 25 (21%) infants had diarrhea. A clinical diagnosis of sepsis was made in 42 (35%) infants and meningitis was diagnosed in 28 (24%) cases. The great majority of sepsis cases (36/86%) occurred in infants less than 15 days of age. In conclusion, non-polio enteroviruses (especially echoviruses) are a common and underreported cause of neonatal infection in the Netherlands in the summer months and are associated with a clinical diagnosis of sepsis or meningitis cases in the first 2 weeks of life in a high proportion of cases.


Assuntos
Enterovirus Humano B/isolamento & purificação , Infecções por Enterovirus/epidemiologia , Enterovirus Humano B/classificação , Infecções por Enterovirus/diagnóstico , Infecções por Enterovirus/virologia , Feminino , Humanos , Recém-Nascido , Doenças do Recém-Nascido/diagnóstico , Doenças do Recém-Nascido/epidemiologia , Doenças do Recém-Nascido/virologia , Masculino , Meningite Viral/diagnóstico , Meningite Viral/epidemiologia , Meningite Viral/virologia , Países Baixos/epidemiologia , Sepse/diagnóstico , Sepse/epidemiologia , Sepse/virologia
18.
Transpl Int ; 14(5): 299-306, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11692213

RESUMO

Explanted hearts were examined to determine whether specific histopathologic features are present in the myocardium of patients with end-stage idiopathic dilated cardiomyopathy (IDC). Extensive histopathologic examination by light microscopy, electron microscopy and immunohistochemistry revealed marked fibrosis in the hearts of 21 of 37 IDC patients and in 26 of 35 patients with heart diseases of known causes. Reactive (interstitial and perivascular) fibrosis predominated in the IDC hearts, whereas both reparative (replacement) fibrosis and reactive fibrosis were found in the comparison group. Endocardial fibroelastosis was found in nine patients with IDC and in 14 patients from the comparison group. Distinct patterns of fibrosis were the sole significant histopathologic difference between myocardial samples from patients with IDC and from those with heart diseases of known causes. The diffuse presence of reactive fibrosis in IDC patients suggests a more generalised dysfunction that affects the composition of the myocardial extracellular matrix.


Assuntos
Cardiomiopatia Dilatada/patologia , Transplante de Coração/fisiologia , Miocárdio/patologia , Adulto , Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/patologia , Núcleo Celular/patologia , Núcleo Celular/ultraestrutura , Feminino , Humanos , Imuno-Histoquímica , Técnicas In Vitro , Inflamação/imunologia , Inflamação/patologia , Miocárdio/imunologia , Miocárdio/ultraestrutura , Seleção de Pacientes , Linfócitos T/imunologia , Linfócitos T/patologia
19.
Ned Tijdschr Geneeskd ; 145(28): 1339-42, 2001 Jul 14.
Artigo em Holandês | MEDLINE | ID: mdl-11484429

RESUMO

A Health Council Committee has advised the Minister of Health, Well-being and Sports not to implement universal hepatitis B vaccination in the Netherlands, as recommended by WHO and requested by members of the Dutch parliament. The Committee argued that the prevalence of hepatitis B carriers among the native Dutch population is so low (0.07%) that universal vaccination is not relevant. In contrast, vaccination was advised for children from parents who had immigrated from middle- and high-endemic countries to the Netherlands, because horizontal transmission is an important route of transmission among these people, as it is in their country of origin. This concerns an estimated 15% of the entire population. For the rest of the Dutch population the risk of horizontal transmission was considered negligible. Sexual transmission was considered more important. The optimal age of vaccination to prevent sexual transmission was considered to be shortly before puberty. The committee concludes that, as yet, no data is available to justify universal vaccination of this age group and highlights the need for additional studies, including those into the efficacy of existing preventive programs, before universal vaccination should be implemented. However, it can be argued that it is unlikely that sufficient information will be available for at least another five years, and it is certain that the risk of sexual transmission will increase during this time. Universal childhood vaccination is an investment in the youth which will pay out in the future, and which should therefore not be postponed.


Assuntos
Emigração e Imigração/estatística & dados numéricos , Vacinas contra Hepatite B/administração & dosagem , Hepatite B/prevenção & controle , Programas de Imunização , Doenças Virais Sexualmente Transmissíveis/prevenção & controle , Adulto , Fatores Etários , Criança , Transmissão de Doença Infecciosa/prevenção & controle , Conselhos de Planejamento em Saúde , Política de Saúde , Hepatite B/epidemiologia , Hepatite B/transmissão , Humanos , Países Baixos/epidemiologia , Guias de Prática Clínica como Assunto , Prevalência
20.
Ned Tijdschr Geneeskd ; 145(13): 616-9, 2001 Mar 31.
Artigo em Holandês | MEDLINE | ID: mdl-11305210

RESUMO

The emergence and re-emergence of viral infections is an ongoing process. Large-scale vaccination programmes led to the eradication or control of some viral infections in the last century, but new viruses are always emerging. Increased travel is leading to a rise in the importation of exotic infections such as dengue and hepatitis E, but also of hepatitis A, which is no longer endemic. Apart from import diseases new viruses have appeared (Nipah-virus and transfusion-transmitted virus). Existing viruses may suddenly cause more severe diseases, e.g. infection by enterovirus 71. The distribution area of a virus may change, e.g. in case of West Nile virus, an Egyptian encephalitis virus that appears to have established itself in the USA. Furthermore, there is no such thing as a completely new virus; it is always an existing virus that has adapted itself to another host or that was already present in humans but has only recently been discovered. A number of factors facilitate the emergence of new infectious diseases. These include intensive animal husbandry and the transport of animals. The unexpected appearance of West Nile virus in the western hemisphere was possibly due to animal transportation.


Assuntos
Criação de Animais Domésticos , Mutação , Viagem , Viroses/epidemiologia , Viroses/transmissão , Vírus/patogenicidade , Animais , Humanos , Estados Unidos/epidemiologia , Viroses/etiologia , Febre do Nilo Ocidental/epidemiologia , Vírus do Nilo Ocidental/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...